Glucagon receptor agonism as a deliberate component of dual and tri-agonists: what it adds in energy expenditure and hepatic fat mobilisation, and what it costs in glycaemic control and heart rate.
What I have: a GLP-1 receptor agonist · cagrilintide. I have used one of these for a while and I am considering switching, which requires a reason. What I care about…
I have the report as a PDF with the chromatogram on page two, so I can quote specifics. This is presented as though it settles something, and I am not convinced it…
I am trying to understand the logic of putting glucagon receptor agonism into a weight-loss molecule, because on the face of it it sounds like a mistake. Glucagon…
The case in front of me: SUSTAIN-6 · oral semaglutide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if…
Details up front: PIONEER-1 · retatrutide. I am asking for verification rather than opinion, ideally with something I can read myself. It is possible the evidence…
REDEFINE 1 reported mean weight loss of about 22.7% for CagriSema at 68 weeks, which as far as I can tell is the largest figure any phase 3 obesity trial has…
Setup, so nobody has to ask: SURMOUNT-OSA · a GLP-1 receptor agonist. I have read the primary source rather than the summary, which has left me with more questions. I…
Details up front: mazdutide · twenty-one days. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring answer. I…
Details up front: 2 mg · retatrutide. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know how…
The specifics, since they change the answer: ATTAIN-1 · semaglutide. Somebody stated this to me confidently and I would like to check it before repeating it. I would…
I have the full paper rather than the abstract, and the supplementary appendix. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware…
For reference: tirzepatide · semaglutide. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments for each and they…
I would like to know how much of this is established and how much is a reasonable story. I have used one of these for a while and I am considering switching, which…
The particulars: tirzepatide · ESSENCE. I understand the observation; what I do not understand is the mechanism behind it. I have read the two review articles that…
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse results